Correction: Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis

PDF  |  How to cite

Oncotarget. 2018; 9:36406-36406. https://doi.org/10.18632/oncotarget.26394

Metrics: PDF 1590 views  |   ?  

Zhun Wang1, Shuanghe Peng1, Ning Jiang1, Aixiang Wang1, Shuguang Liu1, Hui Xie1, Linpei Guo1, Qiliang Cai1 and Yuanjie Niu1

1 Departments of Urology, Tianjin Institute of Urology, The second Hospital of Tianjin Medical University, Tianjin, 300211, China

Published: November 20, 2018

This article has been corrected: The correct Funding information is given below:


This meta-analysis has been financially supported by the National Natural Science Foundation of China (No. 81472682 and No. 81572538) and the Science Foundation of Tianjin (No. 16JCZDJC34400).

Original article: Oncotarget. 2017; 8:102361-102370. DOI: https://doi.org/10.18632/oncotarget.21971.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26394